C9176 Insurance Policy Changes

HCPCS C9176 is officially defined as "Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose." HCPCS C9176 is referenced in 3 tracked payer policy changes from Blue Cross Blue Shield of Rhode Island and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C9176 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.